Genetics and the management of women at high risk for breast cancer

被引:22
|
作者
Mincey, BA [1 ]
机构
[1] Mayo Clin, Jacksonville, FL 32224 USA
来源
ONCOLOGIST | 2003年 / 8卷 / 05期
关键词
BRCA mutations; breast cancer genetics; ovarian cancer genetics; hereditary cancer symdromes;
D O I
10.1634/theoncologist.8-5-466
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is estimated that 5%-10% of all breast cancers in women are associated with hereditary susceptibility due to mutations in autosomal dominant genes, such as BRCA1 and BRCA2, p53, pTEN, and STK11/LKB1. Another 15%-20% of female breast cancers occur in women with a family history but without an apparent autosomal dominant inheritance pattern, and are probably due to other genetic factors with environmental influence. Approximately 7%-10% of ovarian cancers occur in women with hereditary susceptibility, primarily secondary to mutations in BRCA1 and BRCA2, with smaller contributions from mutations in mismatch repair genes associated with the hereditary nonpolyposis colorectal cancer and other, as yet undiscovered, genes.
引用
收藏
页码:466 / 473
页数:8
相关论文
共 50 条
  • [31] Electronic Health Records and the Management of Women at High Risk of Hereditary Breast and Ovarian Cancer
    Drohan, Brian
    Ozanne, Elissa M.
    Hughes, Kevin S.
    [J]. BREAST JOURNAL, 2009, 15 : S46 - S55
  • [32] The management of women at high risk of experiencing hereditary breast and ovarian cancer - The Lahey guidelines
    Hughes, KS
    Roche, CA
    Whitney, T
    McLellan, R
    [J]. DISEASE MANAGEMENT & HEALTH OUTCOMES, 2000, 7 (04) : 201 - 215
  • [33] Management of women at high risk of hereditary breast cancer in the Veneto Regional Program for Prevention
    Del Sole, Annamaria
    Cinquetti, Sandro
    Fedato, Chiara
    Montagna, Marco
    Russo, Francesca
    Sbrogio, Luca Gino
    Zorzi, Manuel
    [J]. EPIDEMIOLOGIA & PREVENZIONE, 2015, 39 (04): : 99 - 101
  • [34] Management of Early Menopause/Premature Ovarian Insufficiency in Women with or at High Risk of Breast Cancer
    Brennan, Annabelle
    Hickey, Martha
    [J]. SEMINARS IN REPRODUCTIVE MEDICINE, 2020, 38 (04/05) : 309 - 314
  • [35] Breast Cancer Screening in Women at Average Risk and High Risk
    Griffin, Jennifer L.
    Pearlman, Mark D.
    [J]. OBSTETRICS AND GYNECOLOGY, 2010, 116 (06): : 1410 - 1421
  • [36] A multidisciplinary risk management clinic for women at high genetic risk of breast and ovarian cancer - Experience and evaluation
    Brennan, M. E.
    Robinson, K.
    Brand, A.
    Kirk, J.
    [J]. BREAST, 2008, 17 (02): : 206 - 207
  • [37] Soy foods for breast cancer survivors and women at high risk for breast cancer?
    Maskarinec, G
    [J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2005, 105 (10) : 1524 - 1528
  • [38] Tamoxifen for the reduction in the incidence of breast cancer in women at high risk for breast cancer
    Honig, SF
    [J]. SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 345 - 348
  • [39] Assessing Risk and Knowledge of Women on Breast Cancer and Providing Lifestyle Advice for the Management of Breast Cancer Risk
    Ghouse, Ishrar Shaik Mohammad
    Prasanth, Neeluri
    Reddy, GaddiGeetha
    Ganga, Madamanchi Manasa
    [J]. INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2021, 11 (04): : L56 - L62
  • [40] Breast Cancer: Genetics and Risk Assessment
    Tejada-Berges, Trevor
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2016, 59 (04): : 673 - 687